Phasix Mesh
Surgical Film. 510(k) K142818, from C. R. Bard (Warwick, RI). Product code OOD, class 2.
As of Nov 17, 2026, K142818 is an FDA 510(k) held by C. R. Bard, substantially equivalent on Mar 31, 2015 after 183 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Mar 31, 2015
- Review time: 183 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Phasix™ Mesh is indicated to reinforce soft tissue where weakness exists in patients undergoing plastic and reconstructive surgery, or for use in procedures involving soft tissue repair, such as the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Tephaflex MeshK113723 · Tepha, Inc. · Feb 15, 2012
- Tephaflex MeshK111946 · Tepha, Inc. · Sep 26, 2011
- Tephaflex Surgical MeshK070894 · Tepha, Inc. · Apr 13, 2007
Cited as a Predicate
2 later 510(k) summaries name this device as a predicate- GalaFLEX LITE ScaffoldK233999 · Tepha, Inc. · Apr 9, 2024
- Phasix MeshK161424 · C.R. Bard, Inc. · Sep 29, 2016
Other OOD Clearances
The newest 510(k)s for the same product code; see every OOD device- GalaFLEX LITE ScaffoldK233999 · Tepha, Inc. · Apr 9, 2024
- SurgiLattice scaffoldK202425 · Tepha, Inc. · Aug 19, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 29, 2014
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files